Life Cycle Investment Partners Ltd
Source: SEC Form 13F · as of Mar 2026Life Cycle Investment Partners Ltd holds 11 biotech & pharma companies tracked by BioSniper, totaling $1.06B in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$1.06B
| Company | Shares | Value |
|---|---|---|
| GMOptec International, Inc. | 3,191,163 | $237.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 440,409 | $196.7M |
| ABBVAbbVie Inc. | 722,848 | $157.2M |
| LLYELI LILLY & Co | 139,583 | $128.4M |
| JNJJOHNSON & JOHNSON | 314,732 | $76.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 227,822 | $61.6M |
| IDXXIDEXX LABORATORIES INC /DE | 109,478 | $61.5M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 177,541 | $58.7M |
| ARGXARGENX SE | 58,867 | $43.0M |
| ELVElevance Health Inc. | 120,938 | $35.4M |
| GILDGILEAD SCIENCES, INC. | 11,553 | $1.6M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.